Improving inclusion of under-served groups in clinical research: guidance from the NIHR-INCLUDE project. National Institute for Health and Care Research www.nihr.ac.uk/documents/improving-inclusion-of-under-served-groups-in-clinical-research-guidance-from-include-project/25435 (2022).
Boden-Albala, B. Confronting legacies of underrepresentation in clinical trials: the case for greater diversity in research. Neuron 110, 746–748 (2022).
Article CAS PubMed Google Scholar
Bodicoat, D. H. et al. Promoting inclusion in clinical trials—a rapid review of the literature and recommendations for action. Trials 22, 880 (2021).
Article PubMed PubMed Central Google Scholar
Beresford, P. User involvement, research and health inequalities: developing new directions. Health Soc. Care Community 15, 306–312 (2007).
Treweek, S., Forouhi, N. G., Narayan, K. M. V. & Khunti, K. COVID-19 and ethnicity: who will research results apply to? Lancet 395, 1955–1957 (2020).
Article CAS PubMed PubMed Central Google Scholar
Khunti, K., Singh, A. K., Pareek, M. & Hanif, W. Is ethnicity linked to incidence or outcomes of covid-19? BMJ 369, m1548 (2020).
Haynes, N., Cooper, L. A., Albert, M. A. Association of Black Cardiologists. At the heart of the matter: unmasking and addressing the toll of COVID-19 on diverse populations. Circulation 142, 105–107 (2020).
Article CAS PubMed Google Scholar
Etti, M. et al. Ethnic minority and migrant underrepresentation in Covid-19 research: causes and solutions. eClinicalMedicine 36, 100903 (2021).
Article PubMed PubMed Central Google Scholar
Bass, S. B. et al. Exploring the engagement of racial and ethnic minorities in HIV treatment and vaccine clinical trials: a scoping review of literature and implications for future research. AIDS Patient Care STDS 34, 399–416 (2020).
Gurwitz, J. H., Col, N. F. & Avorn, J. The exclusion of the elderly and women from clinical trials in acute myocardial infarction. JAMA 268, 1417–1422 (1992).
Article CAS PubMed Google Scholar
Reisner, S. L. et al. “Counting” transgender and gender-nonconforming adults in health research: recommendations from the Gender Identity in US Surveillance Group. Transgend. Stud. Q. 2, 34–57 (2015).
Cruz-Jentoft, A. J., Carpena-Ruiz, M., Montero-Errasquín, B., Sánchez-Castellano, C. & Sánchez-García, E. Exclusion of older adults from ongoing clinical trials about type 2 diabetes mellitus. J. Am. Geriatr. Soc. 61, 734–738 (2013).
Salmasi, V., Lii, T. R., Humphreys, K., Reddy, V. & Mackey, S. C. A literature review of the impact of exclusion criteria on generalizability of clinical trial findings to patients with chronic pain. Pain Rep. 7, e1050 (2022).
Article PubMed PubMed Central Google Scholar
Wong, J. J., Jones, N., Timko, C. & Humphreys, K. Exclusion criteria and generalizability in bipolar disorder treatment trials. Contemp. Clin. Trials Commun. 9, 130–134 (2018).
Article PubMed PubMed Central Google Scholar
Bowleg, L. We’re not all in this together: on COVID-19, intersectionality, and structural inequality. Am. J. Public Health 110, 917 (2020).
Article PubMed PubMed Central Google Scholar
O’Neill, J. et al. Applying an equity lens to interventions: using PROGRESS ensures consideration of socially stratifying factors to illuminate inequities in health. J. Clin. Epidemiol. 67, 56–64 (2014).
Mutale, F. Inclusion of racial and ethnic minorities in cancer clinical trials: 30 years after the NIH revitalization act, where are we? J. Adv. Pract. Oncol. 13, 755–757 (2022).
Article PubMed PubMed Central Google Scholar
Lau, S. W. J. History of FDA Guidance on Drug Evaluation in Older Adult Patients (US Food and Drug Administration, 2021); www.fda.gov/media/147956/download
Regulations, guidance, and reports related to women’s health. US Food and Drug Administration www.fda.gov/science-research/womens-health-research/regulations-guidance-and-reports-related-womens-health (2019).
US Food and Drug Administration. Diversity Plans to Improve Enrollment of Participants from Underrepresented Racial and Ethnic Populations in Clinical Trials Guidance for Industry (US Government, 2022); www.fda.gov/media/157635/download
US Food and Drug Administration. Enhancing the Diversity of Clinical Trial Populations—Eligibility Criteria, Enrollment Practices, and Trial Designs Guidance for Industry (US Government, 2020); www.fda.gov/media/127712/download
Project Equity: generating evidence for diverse populations in oncology. US Food and Drug Administration www.fda.gov/about-fda/oncology-center-excellence/project-equity (2022).
Porroche-Escudero, A. & Popay, J. The Health Inequalities Assessment Toolkit: supporting integration of equity into applied health research. J. Public Health (Oxf.) 43, 567–572 (2021).
Treweek, S. et al. Developing the INCLUDE Ethnicity Framework—a tool to help trialists design trials that better reflect the communities they serve. Trials 22, 337 (2021).
Article PubMed PubMed Central Google Scholar
Miskimen, T., Marin, H. & Escobar, J. Psychopharmacological research ethics: special issues affecting US ethnic minorities. Psychopharmacology (Berl.) 171, 98–104 (2003).
Article CAS PubMed Google Scholar
Roberson, N. L. Clinical trial participation. Viewpoints from racial/ethnic groups. Cancer 74, 2687–2691 (1994).
Article CAS PubMed Google Scholar
Pratt, B. Research for Health Justice: an ethical framework linking global health research to health equity. BMJ Glob. Health 6, e002921 (2021).
Article PubMed PubMed Central Google Scholar
O’Reilly-de Brún, M. et al. Using Participatory Learning & Action research to access and engage with ‘hard to reach’ migrants in primary healthcare research. BMC Health Serv. Res. 16, 25–25 (2016).
Article PubMed PubMed Central Google Scholar
Godden, S., Ambler, G. & Pollock, A. M. Recruitment of minority ethnic groups into clinical cancer research trials to assess adherence to the principles of the Department of Health Research Governance Framework: national sources of data and general issues arising from a study in one hospital trust in England. J. Med. Ethics 36, 358–362 (2010).
Bolen, S. et al. Defining “success” in recruitment of underrepresented populations to cancer clinical trials: moving toward a more consistent approach. Cancer 106, 1197–1204 (2006).
Corbie-Smith, G., Miller, W. C. & Ransohoff, D. F. Interpretations of ‘appropriate’ minority inclusion in clinical research. Am. J. Med. 116, 249–252 (2004).
Cespedes, M. et al. Proactive strategies to optimize engagement of Black, Hispanic/Latinx, transgender, and nonbinary individuals in a trial of a novel agent for HIV pre-exposure prophylaxis (PrEP). PLoS ONE 17, e0267780 (2022).
Article CAS PubMed PubMed Central Google Scholar
Dowling, N. M., Olson, N., Mish, T., Kaprakattu, P. & Gleason, C. A model for the design and implementation of a participant recruitment registry for clinical studies of older adults. Clin. Trials 9, 204–214 (2012).
Article PubMed PubMed Central Google Scholar
Farooqi, A. et al. Increasing Participation of Black Asian and Minority Ethnic Groups in Health and Social Care Research (National Institute for Health and Care Research, 2018); arc-em.nihr.ac.uk/clahrcs-store/increasing-participation-black-asian-and-minority-ethnic-bame-groups-health-and-social
Bonevski, B. et al. Reaching the hard-to-reach: a systematic review of strategies for improving health and medical research with socially disadvantaged groups. BMC Med. Res. Methodol. 14, 42 (2014).
Article PubMed PubMed Central Google Scholar
Versavel, S. et al. Diversity, equity, and inclusion in clinical trials: a practical guide from the perspective of a trial sponsor. Contemp. Clin. Trials 126, 107092 (2023).
George, S., Duran, N. & Norris, K. A systematic review of barriers and facilitators to minority research participation among African Americans, Latinos, Asian Americans, and Pacific Islanders. Am. J. Public Health 104, e16–e31 (2014).
Article PubMed PubMed Central Google Scholar
Heidari, S., Babor, T. F., De Castro, P., Tort, S. & Curno, M. Sex and Gender Equity in Research: rationale for the SAGER guidelines and recommended use. Res. Integr. Peer Rev. 1, 2 (2016).
Article PubMed PubMed Central Google Scholar
Witham, M. D. et al. Developing a roadmap to improve trial delivery for under-served groups: results from a UK multi-stakeholder process. Trials 21, 694 (2020).
Article PubMed PubMed Central Google Scholar
Wang, X. et al. Systematic approach to outcome assessment from coded electronic healthcare records in the DaRe2THINK NHS-embedded randomized trial. Eur. Heart J. Digit. Health 3, 426–436 (2022).
Article CAS PubMed PubMed Central Google Scholar
Vertovec, S. Super-diversity and its implications. Ethn. Racial Stud. 30, 1024–1054 (2007).
Munn, Z., Stern, C., Aromataris, E., Lockwood, C. & Jordan, Z. What kind of systematic review should I conduct? A proposed typology and guidance for systematic reviewers in the medical and health sciences. BMC Med. Res. Methodol. 18, 5 (2018).
Comments (0)